A registry of patients with inflammatory bowel diseases, ulcerative colitis (UC) and Crohn's disease (CD), was created at the University of Puerto Rico in 1995. Subjects with a documented diagnosis of IBD by clinical, radiologic, endoscopic, and/or pathologic criteria were recruited from the IBD clinics, support groups, and community practices, and demographic and medical data was collected. All entries from 1995 to 2009 were analyzed for demographics, family history, disease extent, extraintestinal manifestations, surgery, and smoking history. Results were described using summary statistics. 635 Hispanics living in Puerto Rico, 299 with UC and 336 with CD, were included. Mean ages were 40.3 for UC and 30.9 for CD. Over half (56%) of UC and 41% of CD were females. Family history was present in 19.3% of UC and 17.5% of CD. Surgery for IBD had been performed in 31.9% of UC and 51.2% of the CD patients. Over one-fourth of the patients reported extraintestinal manifestations, most frequently arthropathies. Our findings contribute to the limited epidemiologic and clinical data on Hispanics with IBD.

TIVA with midazolam, remifentanil, propofol and cisatracurium was found to be effective, secure, predictable and economic for the anesthetic management of morbidly obese patients.

No abstract

Desarrollo infantil temprano y discapacidad 17 viable, confiable y con valores ideales de especificidad y sensibilidad superiores a 0.70. Para conocer estos valores es necesario que las pruebas sean sometidas a un proceso de validación concurrente que busque conocer la medida en la que coinciden los resultados de dicha prueba, con las evaluaciones diagnósticas consideradas "estándar de oro" o con aquellas habitualmente utilizadas y consideradas de referencia. 10 Se realizó una revisión sistemática de las pruebas de tamizaje de problemas en el desarrollo infantil para niños menores de cinco años, validadas en América (de 1988 a 2012), con los siguientes resultados: 11

No abstract